Search for: All records

Abstract Dynamic liquid crystal elastomers (LCEs) are a class of polymer networks characterized by the inclusion of both liquid crystalline monomers and dynamic covalent bonds. The unique properties realized through the combination of these moieties has produced a plethora of stimuli‐responsive materials to address a range of emerging technologies. While previous works have studied the incorporation of different dynamic bonds in LCEs, few (if any) have studied the effect of the specific placement of the dynamic bonds within an LCE network. A series of dynamic LCE networks were synthesized using a generalizable approach that employs a tandem thiol‐ene/yne chemistry which allows the location of the dynamic disulfide bond to be varied while maintaining similar network characteristics. When probing these systems in the LC regime, the thermomechanical properties were found to be largely similar. It is not until elevated temperatures (160–180 °C) that differences in the relaxation activation energies of these systems begin to materialize based solely on differences in placement of the dynamic bond throughout the network. This work demonstrates that through intentional dynamic bond placement, stress relaxation times can be tuned without affecting the LCE character. This insight can help optimize future dynamic LCE designs and achieve shorter processing times. 

Fluoroether solvents are promising electrolyte candidates for high-energy-density lithium metal batteries, where high ionic conductivity and oxidative stability are important metrics for design of new systems. Recent experiments have shown that these performance metrics, particularly stability, can be tuned by changing the fraction of ether and fluorine content. However, little is known about how different molecular architectures influence the underlying ion transport mechanisms and conductivity. Here, we use all-atom molecular dynamics simulations to elucidate the ion transport and solvation characteristics of fluoroether chains of varying length, and having different ether segment and fluorine terminal group contents. The design rules that emerge from this effort are that solvent size determines lithium-ion transport kinetics, solvation structure, and solvation energy. In particular, the mechanism for lithium-ion transport is found to shift from ion hopping between solvation sites located in different fluoroether chains in short-chain solvents, to ion–solvent co-diffusion in long-chain solvents, indicating that an optimum exists for molecules of intermediate length, where hopping is possible but solvent diffusion is fast. Consistent with these findings, our experimental measurements reveal a non-monotonic behavior of the effects of solvent size on lithium-ion conductivity, with a maximum occurring for medium-length solvent chains. A key design principle for achieving high ionic conductivity is that a trade-off is required between relying on shorter fluoroether chains having high self-diffusivity, and relying on longer chains that increase the stability of local solvation shells. 

Recently, a high-throughput screen of 1900 clinically used drugs identified masitinib, an orally bioavailable tyrosine kinase inhibitor, as a potential treatment for COVID-19. Masitinib acts as a broad-spectrum inhibitor for human coronaviruses, including SARS-CoV-2 and several of its variants. In this work, we rely on atomistic molecular dynamics simulations with advanced sampling methods to develop a deeper understanding of masitinib’s mechanism of Mpro inhibition. To improve the inhibitory efficiency and to increase the ligand selectivity for the viral target, we determined the minimal portion of the molecule (fragment) that is responsible for most of the interactions that arise within the masitinib-Mpro complex. We found that masitinib forms highly stable and specific H-bond interactions with Mpro through its pyridine and aminothiazole rings. Importantly, the interaction with His163 is a key anchoring point of the inhibitor, and its perturbation leads to ligand unbinding within nanoseconds. Based on these observations, a small library of rationally designed masitinib derivatives (M1–M5) was proposed. Our results show increased inhibitory efficiency and highly reduced cytotoxicity for the M3 and M4 derivatives compared to masitinib.